Johnson Y.N. Lau

11.2k total citations · 3 hit papers
134 papers, 8.2k citations indexed

About

Johnson Y.N. Lau is a scholar working on Hepatology, Epidemiology and Molecular Biology. According to data from OpenAlex, Johnson Y.N. Lau has authored 134 papers receiving a total of 8.2k indexed citations (citations by other indexed papers that have themselves been cited), including 111 papers in Hepatology, 92 papers in Epidemiology and 21 papers in Molecular Biology. Recurrent topics in Johnson Y.N. Lau's work include Hepatitis C virus research (104 papers), Hepatitis B Virus Studies (74 papers) and Liver Disease Diagnosis and Treatment (57 papers). Johnson Y.N. Lau is often cited by papers focused on Hepatitis C virus research (104 papers), Hepatitis B Virus Studies (74 papers) and Liver Disease Diagnosis and Treatment (57 papers). Johnson Y.N. Lau collaborates with scholars based in United States, Japan and Hong Kong. Johnson Y.N. Lau's co-authors include Gary L. Davis, David R. Nelson, Ching‐Lung Lai, Etsuro Orito, Judith C. Wilber, Paul Neuwald, Kui Qian, M. S. Urdea, Masashi Mizokami and Teresa L. Wright and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and Nucleic Acids Research.

In The Last Decade

Johnson Y.N. Lau

132 papers receiving 7.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Significance of serum hepatitis C virus RNA levels in chronic hepatitis C

1993 727 citations Johnson Y.N. Lau, Gary L. Davis et al. The Lancet profile →
Association of Diabetes Mellitus and Chronic Hepatitis C Virus Infection

1999 523 citations Johnson Y.N. Lau, Keping Qian et al. Hepatology profile →
A quantitative test to estimate neutralizing antibodies to the hepatitis C virus: cytofluorimetric assessment of envelope glycoprotein 2 binding to target cells.

1996 305 citations Johnson Y.N. Lau et al. profile →

Peers

Countries citing papers authored by Johnson Y.N. Lau

Since Specialization

Citations

This map shows the geographic impact of Johnson Y.N. Lau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Johnson Y.N. Lau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Johnson Y.N. Lau more than expected).

Fields of papers citing papers by Johnson Y.N. Lau

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Johnson Y.N. Lau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Johnson Y.N. Lau. The network helps show where Johnson Y.N. Lau may publish in the future.

Co-authorship network of co-authors of Johnson Y.N. Lau

This figure shows the co-authorship network connecting the top 25 collaborators of Johnson Y.N. Lau. A scholar is included among the top collaborators of Johnson Y.N. Lau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Johnson Y.N. Lau. Johnson Y.N. Lau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	RNAi-based treatment of chronically infected patients and chimpanzees reveals that integrated hepatitis B virus DNA is a source of HBsAg 2017 ·Science Translational Medicine ·Christine I. Wooddell, Man‐Fung Yuen, Henry Lik‐Yuen Chan, Robert G. Gish, Stephen Locarnini, Deborah Chavez, Carlo Ferrari, Bruce D. Given, James Hamilton, Steven B. Kanner, Ching‐Lung Lai, Johnson Y.N. Lau, Thomas Schluep, (unknown), Robert E. Lanford, David L. Lewis	342
2	Specific, sensitive and accurate LC–MS/MS method for the measurement of levovirin in rat and monkey plasma 2002 ·Journal of Pharmaceutical and Biomedical Analysis ·Chin‐Chung Lin, Johnson Y.N. Lau	12
3	A Novel Mechanism to Ensure Terminal Initiation by Hepatitis C Virus NS5B Polymerase 2001 ·Virology ·Zhi Hong, Craig E. Cameron, Michelle Walker, Christian Castro, Nanhua Yao, Johnson Y.N. Lau, Weidong Zhong	164
4	TT virus infection in patients with chronic hepatitis C virus infection - effect of primers, prevalence, and clinical significance 2000 ·Journal of Hepatology ·M Mizokami, Janice K. Albrecht, (unknown), (unknown), (unknown), Zachary Goodman, Zhi Hong, Johnson Y.N. Lau	22
5	Interleukin 10 treatment reduces fibrosis in patients with chronic hepatitis C: A pilot trial of interferon nonresponders 2000 ·Gastroenterology ·David R. Nelson, Gregory Y. Lauwers, Johnson Y.N. Lau, Gary L. Davis	290
6	ANTIBODY TO THE HOST CELLULAR GENE-DERIVED EPITOPE GOR-1 IN LIVER TRANSPLANT RECIPIENTS WITH HEPATITIS C VIRUS INFECTION1 1997 ·Transplantation ·Markus Reiser, Norah A. Terrault, David R. Nelson, M Mizokami, (unknown), John R. Lake, John P. Roberts, Nancy L. Ascher, Teresa L. Wright, Johnson Y.N. Lau	1
7	Transforming growth factor‐ß₁ in chronic hepatitis C 1997 ·Journal of Viral Hepatitis ·David R. Nelson, Regino P. González‐Peralta, Kui Qian, (unknown), Constantine G. Marousis, Gary L. Davis, Johnson Y.N. Lau	112
8	HIGH PREVALENCE OF GB VIRUS-C/HEPATITIS G VIRUS INFECTION IN LIVER TRANSPLANT RECIPIENTS1 1997 ·Transplantation ·Rolland C. Dickson, Keping Qian, Johnson Y.N. Lau	16
9	Vertical Transmission of Hepatitis C 1996 ·Journal of Pediatric Gastroenterology and Nutrition ·Robert G. Gish, Kenneth L. Cox, Masashi Mizokami, Tomoyoshi Ohno, Johnson Y.N. Lau	1
10	Plasma glutathione concentration in patients with chronic hepatitis C virus infection 1995 ·Journal of Viral Hepatitis ·Herbert L. Lim, Brent Myers, Bruce A. Hamilton, Gary L. Davis, Johnson Y.N. Lau	16
11	Localization of Rat Small Intestine Glutamine Synthetase Using Immunofluorescence and In Situ Hybridization 1995 ·Journal of Parenteral and Enteral Nutrition ·(unknown), Vivek B. Shenoy, Ratna Chakrabarti, Johnson Y.N. Lau, Josef Neu	21
12	Loss of serum HCV RNA at week 4 of interferon‐α therapy is associated with more favorable long‐term response in patients with chronic hepatitis C 1995 ·Journal of Medical Virology ·Etsuro Orito, Masashi Mizokami, Kaoru Suzuki, Ken‐ichi Ohba, Tomoyoshi Ohno, (unknown), K. Hayashi, Koji Kato, Shiro Iino, Johnson Y.N. Lau	93
13	Detection of hepatitis C virus genome in formalin‐fixed paraffin‐embedded liver tissue by in situ reverse transcription polymerase chain reaction 1994 ·Journal of Medical Virology ·George Lau, Jane Fang, Peiwen Wu, Gary L. Davis, Johnson Y.N. Lau	18
14	Detection of hepatitis c virus rna genome in liver tissue by nonisotopic in situ hybridization 1994 ·Journal of Medical Virology ·Johnson Y.N. Lau, Gary L. Davis	19
15	Immunoglobulin M and A antibodies to hepatitis C core antigen in chronic hepatitis C virus infection 1994 ·Journal of Medical Virology ·George Lau, Richard R. Lesniewski, (unknown), Gary L. Davis, Johnson Y.N. Lau	9
16	Cholestatic hepatitis leading to hepatic failure in a patient with organ-transmitted hepatitis C virus infection 1994 ·Gastroenterology ·Herbert L. Lim, George Lau, Gary L. Davis, David J. Dolson, Johnson Y.N. Lau	107
17	Optimization for the detection of hepatitis C virus antigens in the liver 1994 ·Journal of Hepatology ·Regino P. González‐Peralta, Jane Fang, Gary L. Davis, Robert G. Gish, Kyoko Tsukiyama–Kohara, Michinori Kohara, Mario U. Mondelli, Richard R. Lesniewski, M. Ian Phillips, Masashi Mizokami, Johnson Y.N. Lau	48
18	Molecular virology and pathogenesis of hepatitis B 1993 ·The Lancet ·Johnson Y.N. Lau	156
19	Interferon-γ receptor expression in chronic hepatitis B virus infection 1992 ·Journal of Hepatology ·Johnson Y.N. Lau, Alan Morris, Graeme J.M. Alexander, Roger Williams	2
20	Increased tumor necrosis factor-α receptor number in chronic hepatitis B virus infection 1991 ·Hepatology ·Johnson Y.N. Lau, Nick Sheron, Kayhan T. Nouri‐Aria, Graeme J.M. Alexander, Roger Williams	13

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact